Management of Mild to Moderate Asthma

Slides:



Advertisements
Similar presentations
Food and Drug Administration Division of Pulmonary and Allergy Drug Products Summary Comments - Orally Inhaled and Intranasal Budesonide and Fluticasone.
Advertisements

Taking your medications properly and safely Cherokee Layson-Wolf, PharmD, CGP, BCACP, FAPhA Assistant Dean, Experiential Learning Associate Professor,
Quick Fixes for Poor Asthma Control Barbara Carroll Langham RN,BSN Pediatric Asthma Care Manager Kaiser Permanente.
The Patient Experience With Systemic Lupus Erythematosus
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Moderate-to-Severe Asthma Management
COPD Management.
Clinical Trials in IBD.
Why Gene Therapy for Hemophilia?
Treatment Strategies in Mild to Moderate COPD
Advances in Managing Inhibitors in Patients With Hemophilia A
Pseudomonas Lung Infections in Cystic Fibrosis
Progression After Cancer Immunotherapy in Advanced NSCLC
Chronic Rhinosinusitis
Chronic Rhinosinusitis
COPD Management.
Ask the Onychomycosis Expert, Part 2
Improving Acne Outcomes
Patient-Centered Care in Cystic Fibrosis
Advances in Dry Eye.
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Organizational Culture in the Oncology Medical Home
Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.
An Interprofessional Approach to the Patient With Chronic Airway Disease.
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Chronic Idiopathic Urticaria
Addressing Disease Burden in Asthma
Asthma and Atopic Comorbidities
The Evolving Role of Immunotherapy in NSCLC
Immunotherapy in Pancreatic Cancer: Thinking Outside the Box
Talking to Patients About Diabetes Management
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Multidisciplinary Perspectives on Interstitial Lung Diseases
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Hyperhidrosis Is Burdensome!
Gene Therapy: Past, Present, and Future
Mild to Moderate Asthma
Tackling Atopic Dermatitis
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
A Primer on Medication Delivery Systems in COPD Management
Perspectives on the Impact of Inflammation in OA
Updates in Neurogenic Orthostatic Hypotension
New Recommendations on How to Stage Hidradenitis Suppurativa
When Is Biologic Therapy Appropriate for HS?
What Is Bipolar Disorder?
Management of Systematic Lupus Erythematosus
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Parkinson Disease Psychosis
Talking With Your Patients About Excessive Sweating
A Primer on Medication Delivery Systems in COPD Management
Understanding and Addressing the Needs of Patients With AD
Treatment-Resistant Schizophrenia
Guide to Atopic Dermatitis
Atopic Dermatitis in the Pediatric Practice
EGPA.
The Burden of Psoriasis:
Patient Questions and Expert Answers in Psoriasis:
Severe Asthma and Comorbidities
Optimizing Joint Health in Hemophilia
Critical Decision Points in Insomnia
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
Novel Concepts in the Management of RCC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
From Adjuvant to Metastatic in Melanoma
8 Medication Errors and Prevention.
The Building Blocks of Homocystinuria and Homocysteinemia Management
Immune Checkpoint Inhibitors in Lung Cancer
Ask the Psoriasis Expert
Foundations of Asthma.
Presentation transcript:

Management of Mild to Moderate Asthma

This program will include a discussion of off-label treatment and investigational devices not approved by the Food and Drug Administration for use in the United States.

Asthma in the United States: A Snapshot

Medication Adherence in Chronic Disease

Payers Are Concerned About Medication Adherence

Perspectives on Payer Management of Patients With Asthma to Minimize Costs of Care

Poor Asthma Medication Adherence What's It About?

Special Challenges

Nonadherence: The Elephant in the Room

Spectrum of Assessment of Adherence

Gold Standard: Electronic Monitoring

Proper Inhaler Technique Is Critical to Adherence and Asthma Control

Better Technique Leads to Better Adherence Emphasize Avoidance of Critical Errors

Monitoring Adherence to Asthma Therapy What's in the Future?

Payer's Perspective on Electronic Monitoring

Is Electronic Monitoring a Privacy Issue? Maybe Not So Much

Confronting Nonadherence They Didn't Teach That in Medical School

Finding Time for Care Management in Practice

Concluding Remarks

Abbreviations